- Home
- CTMX vs RRGB Comparison
CTMX vs RRGB Comparison
Compare CTMX & RRGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- RRGB
- Stock Information
- Founded
- CTMX 2008
- RRGB 1969
- Country
- CTMX United States
- RRGB United States
- Employees
- CTMX N/A
- RRGB N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- RRGB Restaurants
- Sector
- CTMX Health Care
- RRGB Consumer Discretionary
- Exchange
- CTMX Nasdaq
- RRGB Nasdaq
- Market Cap
- CTMX 444.3M
- RRGB 88.7M
- IPO Year
- CTMX 2015
- RRGB 2002
- Fundamental
- Price
- CTMX $2.48
- RRGB $6.89
- Analyst Decision
- CTMX Strong Buy
- RRGB Strong Buy
- Analyst Count
- CTMX 2
- RRGB 4
- Target Price
- CTMX $5.00
- RRGB $11.88
- AVG Volume (30 Days)
- CTMX 2.7M
- RRGB 564.7K
- Earning Date
- CTMX 08-07-2025
- RRGB 08-21-2025
- Dividend Yield
- CTMX N/A
- RRGB N/A
- EPS Growth
- CTMX 128.27
- RRGB N/A
- EPS
- CTMX 0.49
- RRGB N/A
- Revenue
- CTMX $147,557,000.00
- RRGB $1,252,370,000.00
- Revenue This Year
- CTMX N/A
- RRGB $0.04
- Revenue Next Year
- CTMX N/A
- RRGB N/A
- P/E Ratio
- CTMX $5.11
- RRGB N/A
- Revenue Growth
- CTMX 23.81
- RRGB N/A
- 52 Week Low
- CTMX $0.40
- RRGB $2.50
- 52 Week High
- CTMX $3.10
- RRGB $7.05
- Technical
- Relative Strength Index (RSI)
- CTMX 56.59
- RRGB 71.49
- Support Level
- CTMX $2.15
- RRGB $5.41
- Resistance Level
- CTMX $2.44
- RRGB $5.76
- Average True Range (ATR)
- CTMX 0.24
- RRGB 0.46
- MACD
- CTMX -0.05
- RRGB 0.05
- Stochastic Oscillator
- CTMX 39.71
- RRGB 100.00
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About RRGB Red Robin Gourmet Burgers Inc.
Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. Its brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue. The company has one operating and one reportable segment: restaurants.